Biotechnology Assets, S.A. (BST:041)
Germany flag Germany · Delayed Price · Currency is EUR
0.3600
+0.0210 (6.19%)
At close: Jul 3, 2025

Biotechnology Assets Statistics

Total Valuation

BST:041 has a market cap or net worth of EUR 27.76 million. The enterprise value is 29.58 million.

Market Cap 27.76M
Enterprise Value 29.58M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Current Share Class 68.03M
Shares Outstanding n/a
Shares Change (YoY) +14.28%
Shares Change (QoQ) +7.05%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 9.36
PB Ratio 4.20
P/TBV Ratio 6.55
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -10.14
EV / Sales 9.98
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -337.57

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 0.32.

Current Ratio 0.81
Quick Ratio 0.81
Debt / Equity 0.32
Debt / EBITDA n/a
Debt / FCF -23.81
Interest Coverage -12.62

Financial Efficiency

Return on equity (ROE) is -44.40% and return on invested capital (ROIC) is -14.77%.

Return on Equity (ROE) -44.40%
Return on Assets (ROA) -9.11%
Return on Invested Capital (ROIC) -14.77%
Return on Capital Employed (ROCE) -22.36%
Revenue Per Employee 87,210
Profits Per Employee -85,803
Employee Count 34
Asset Turnover 0.19
Inventory Turnover n/a

Taxes

Income Tax -139,119
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +56.52% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +56.52%
50-Day Moving Average 0.23
200-Day Moving Average 0.22
Relative Strength Index (RSI) 64.11
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BST:041 had revenue of EUR 2.97 million and -2.92 million in losses. Loss per share was -0.04.

Revenue 2.97M
Gross Profit 2.62M
Operating Income -2.29M
Pretax Income -3.06M
Net Income -2.92M
EBITDA -1.29M
EBIT -2.29M
Loss Per Share -0.04
Full Income Statement

Balance Sheet

The company has 261,856 in cash and 2.09 million in debt, giving a net cash position of -1.82 million.

Cash & Cash Equivalents 261,856
Total Debt 2.09M
Net Cash -1.82M
Net Cash Per Share n/a
Equity (Book Value) 6.61M
Book Value Per Share 0.10
Working Capital -851,300
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -73,854 and capital expenditures -13,765, giving a free cash flow of -87,619.

Operating Cash Flow -73,854
Capital Expenditures -13,765
Free Cash Flow -87,619
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 88.19%, with operating and profit margins of -77.17% and -98.39%.

Gross Margin 88.19%
Operating Margin -77.17%
Pretax Margin -103.08%
Profit Margin -98.39%
EBITDA Margin -43.60%
EBIT Margin -77.17%
FCF Margin n/a

Dividends & Yields

BST:041 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -14.28%
Shareholder Yield n/a
Earnings Yield -10.51%
FCF Yield -0.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BST:041 has an Altman Z-Score of -8.07 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -8.07
Piotroski F-Score 2